interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Drug shortage outlook › Mylan Institutional, a Viatr

Shortage outlook · by company · read 11 November 2026

Which drugs does Mylan Institutional, a Viatris Company have on the FDA shortage list?

Mylan Institutional, a Viatris Company has 15 presentations of 6 drugs on the FDA shortage list, 1 of them reported unavailable. Each is the company's own report to the FDA, with the date of its last update. A report is the company's statement, not a check of any pharmacy's stock.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.
Mylan Institutional, a Viatris Companycompany reports to the FDA shortage list
6drugs on the list

Mylan Institutional, a Viatris Company has 15 presentations of 6 drugs on the FDA shortage list in 11 November 2026.

The company reported 14 available, 0 with limited availability and 1 unavailable.

Drug by drug, as the company reported it

  • Rifampin1 presentation · on the list 5 years and 8 months · last updated 3 November 2026
  • Dexamethasone Sodium Phosphate4 presentations · on the list 7 years and 6 months · last updated 3 November 2026
  • Dexmedetomidine Hydrochloride3 presentations · on the list 6 years and 6 months · last updated 3 November 2026
  • Remifentanil Hydrochloride3 presentations · on the list 4 years and 4 months · last updated 3 November 2026
  • Etomidate2 presentations · on the list 4 years · last updated 3 November 2026
  • Rocuronium Bromide2 presentations · on the list 3 years and 8 months · last updated 3 November 2026

FDA current shortage listing file, read 11 November 2026. Availability is the company's own statement to the FDA, not a check of any pharmacy's stock.

Where can you go from here?

Look up any medicine to see how long it has been listed and every company that reports it. The FDA explains what a listing means in the FDA's frequently asked questions about drug shortages, and the list itself is the FDA drug shortages database.